Publisher
Springer International Publishing
Reference8 articles.
1. Allen, M. S., & Drash, E. C. (1968). Primary malignant melanoma of the lung. Cancer, 21, 154–159.
2. Blokx, W. A., Van Dijk, M. C., & Ruiter, D. J. (2010). Molecular cytogenetics of cutaneous melanocytic lesions – diagnostic, prognostic and therapeutic aspects. Histopathology, 56(1), 121–132.
3. Burgiero, A., Mollinedo, F., & Oliviera, J. (2013). Ipilimumab and vemurafenib: Two different routes for targeting melanoma. Current Cancer Drug Targets, 13, 879. Epub ahead of print.
4. Das, P., Kumar, N., Ahuja, A., Jain, A., Ray, R., Sarkar, C., & Gupta, S. D. (2010). Primary malignant melanoma at unusual sites: An institutional experience with review of the literature. Melanoma Research, 20(3), 233–239.
5. Jennings, T. A., Axiotis, C. A., Kress, Y., & Carter, D. (1990). Primary malignant melanoma of the lower respiratory tract. Report of a case and literature review. American Journal of Clinical Pathology, 94, 649–655.